Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | 3 | GRO-a | 51.0 | 45 | ||||
RA1869 | 3 | GRO-a | 76.0 | 53 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 3 | GRO-a | 1296.0 | 41 | ||||
N2759 | 3 | GRO-a | 1234.5 | 42 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | GRO-a | 248.5 | 40 | ||||
RA1931 | 3 | GRO-a | 163.0 | 45 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | GRO-a | 991.0 | 39 | ||||
N2586 | 3 | GRO-a | 1658.0 | 41 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 41.0 | 43 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 218.0 | 64 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 1042.0 | 47 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 2415.0 | 53 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 177.0 | 53 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 6946.5 | 58 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 1201.0 | 50 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 6290.0 | 50 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 5092.0 | 39 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 13603.0 | 39 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 16325.0 | 51 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 16326.0 | 55 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 16608.0 | 41 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 17358.0 | 53 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 17427.0 | 43 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | GRO-a | 17222.0 | 45 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | GRO-a | 125.0 | 37 |